latest
.previous efforts to treat babies with the same protein shortly after birth had failed, schneider said.
., looking for billing codes to identify emergency room visits, observation stays, and inpatient hospitalizations
. may 16, 2018
. print
.
.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
may 16, 2018
.